Vulvar Cancer in the North of Israel

Purpose: This is a population study of patients who were treated for vulvar cancer in a tertiary center in northern Israel, aimed to report clinical findings, treatment, and outcome. Methods: A retrospective chart review of all medical records of consecutive patients who were treated for vulvar c...

Full description

Bibliographic Details
Main Authors: Orit Kaidar-Person, Nour Ibrahim, Amnon Amit, Roxolyana Bortnyak-Abdah
Format: Article
Language:English
Published: Rambam Health Care Campus 2014-07-01
Series:Rambam Maimonides Medical Journal
Subjects:
Online Access:http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=409
_version_ 1811279996645277696
author Orit Kaidar-Person
Nour Ibrahim
Amnon Amit
Roxolyana Bortnyak-Abdah
author_facet Orit Kaidar-Person
Nour Ibrahim
Amnon Amit
Roxolyana Bortnyak-Abdah
author_sort Orit Kaidar-Person
collection DOAJ
description Purpose: This is a population study of patients who were treated for vulvar cancer in a tertiary center in northern Israel, aimed to report clinical findings, treatment, and outcome. Methods: A retrospective chart review of all medical records of consecutive patients who were treated for vulvar cancer in the years 1993–2012 was conducted. Data extracted from the medical records included demographics, histology, size of lesion, stage of disease at diagnosis, type of treatment, radiation dose, follow-up, recurrence, and survival. Results: The study included 44 patients with a median age of 69.8 years (range, 42–93 years). Thirty-five (79.5%) of the patients were of Jewish descent, five were Arabic, and four were of other descent. The most common histology type was squamous cell carcinoma in 35 (79.5%) patients. Most patients were staged FIGO II–III at time of diagnosis. Surgery was the most common primary treatment modality (54.2%). Twenty-three (52.2%) patients had recurrent disease. Older age and more advanced stage at diagnosis were associated with increased mortality. Conclusion: Vulvar cancer is common among elderly women with co-morbidities who present in advanced disease stage; all these factors are significant for survival.
first_indexed 2024-04-13T01:06:55Z
format Article
id doaj.art-9bb0ddd11a8d4b4ba6feb83b6316c115
institution Directory Open Access Journal
issn 2076-9172
language English
last_indexed 2024-04-13T01:06:55Z
publishDate 2014-07-01
publisher Rambam Health Care Campus
record_format Article
series Rambam Maimonides Medical Journal
spelling doaj.art-9bb0ddd11a8d4b4ba6feb83b6316c1152022-12-22T03:09:20ZengRambam Health Care CampusRambam Maimonides Medical Journal2076-91722014-07-0153e002210.5041/RMMJ.10156Vulvar Cancer in the North of IsraelOrit Kaidar-Person0Nour Ibrahim1Amnon Amit2Roxolyana Bortnyak-Abdah3Division of Oncology, Rambam Health Care Campus, Haifa, IsraelDivision of Oncology, Rambam Health Care Campus, Haifa, IsraelGyneco-Oncology Unit, Rambam Health Care Campus, Haifa, IsraelDivision of Oncology, Rambam Health Care Campus, Haifa, IsraelPurpose: This is a population study of patients who were treated for vulvar cancer in a tertiary center in northern Israel, aimed to report clinical findings, treatment, and outcome. Methods: A retrospective chart review of all medical records of consecutive patients who were treated for vulvar cancer in the years 1993–2012 was conducted. Data extracted from the medical records included demographics, histology, size of lesion, stage of disease at diagnosis, type of treatment, radiation dose, follow-up, recurrence, and survival. Results: The study included 44 patients with a median age of 69.8 years (range, 42–93 years). Thirty-five (79.5%) of the patients were of Jewish descent, five were Arabic, and four were of other descent. The most common histology type was squamous cell carcinoma in 35 (79.5%) patients. Most patients were staged FIGO II–III at time of diagnosis. Surgery was the most common primary treatment modality (54.2%). Twenty-three (52.2%) patients had recurrent disease. Older age and more advanced stage at diagnosis were associated with increased mortality. Conclusion: Vulvar cancer is common among elderly women with co-morbidities who present in advanced disease stage; all these factors are significant for survival.http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=409Chemotherapyradiotherapysurgeryvulvar cancer
spellingShingle Orit Kaidar-Person
Nour Ibrahim
Amnon Amit
Roxolyana Bortnyak-Abdah
Vulvar Cancer in the North of Israel
Rambam Maimonides Medical Journal
Chemotherapy
radiotherapy
surgery
vulvar cancer
title Vulvar Cancer in the North of Israel
title_full Vulvar Cancer in the North of Israel
title_fullStr Vulvar Cancer in the North of Israel
title_full_unstemmed Vulvar Cancer in the North of Israel
title_short Vulvar Cancer in the North of Israel
title_sort vulvar cancer in the north of israel
topic Chemotherapy
radiotherapy
surgery
vulvar cancer
url http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=409
work_keys_str_mv AT oritkaidarperson vulvarcancerinthenorthofisrael
AT nouribrahim vulvarcancerinthenorthofisrael
AT amnonamit vulvarcancerinthenorthofisrael
AT roxolyanabortnyakabdah vulvarcancerinthenorthofisrael